Friday’s Stock Surge Daily
Click here to view this email in your browser.
<[link removed]>
Click here to unsubscribe.
<[link removed]>
View the Digital Edition Here
<[link removed]>
Hey, Ross here:
Earnings season has begun.
And despite all the worries about the economy, the consumer, and the potential
AI bubble…
As today’s chart shows, this key driver of stock prices is still doing well.
Chart of the Day
This chart shows the number of S&P 500 companies issuing positive earnings
guidance by quarter.
The horizontal dotted lines show the five and ten-year averages for the number
of companies issuing positive guidance.
As you can see for the past three quarters – including the fourth quarter of
2025, which is the current earnings season…
Positive guidance has been reliably above the five and ten-year averages.
And when you look at the flip side – the number of companies issuing negative
earnings guidance…
You’ll find a congruent picture, with those numbers being lower than the
average.
To sum it up, corporate earnings are strong.
In the longer term, this will help support stock prices.
In the shorter term – it’s a fast-moving opportunity.
I explain more below.
Insight of the Day
Strong earnings + weak sentiment = overreaction opportunity
Right now, sentiment around the economy and consumer spending is pretty
negative…
Meaning investors tend to “overreact” to earnings.
What that means is that when earnings fall even a little below expectations…
Stocks can sell off heavily – way out of line with reality.
But that earnings overreaction is an opportunity…
Especially for the corporate insiders – high-ranking executives like CEOs,
CFOs, and Directors – exploiting an SEC loophole to snap up their own company
shares.
It happened to Alumis Inc. (ALMS) back in mid-November last year.
It sold off heavily after earnings…
But just a few days later, several key insiders bought in big.
I noticed, and issued a buy recommendation to my Insider Effect members.
Six weeks later, the company announced successful Phase 3 clinical trial
results for its plaque psoriasis drug…
And the stock exploded.
Members had the chance to lock in nearly 250% gains on the stock itself…
And over 1,250% on the options – all in less than two months.
That’s the power of following the insiders taking advantage of these earnings
overreactions.
And later this morning at 11 a.m. Eastern…
I’m going to walk you through exactly how this insider strategy works
step-by-step…
So that you too will know how to profit from these overreactions.
I must warn you though…
Not all insiders are created equal…
And following the wrong insiders could put you on the wrong side of these
overreactions instead.
After my live insider walkthrough later this morning, that won’t happen to you…
Because I’ll show you the exact type of insider buying you want to follow –
and the kind you want to avoid at all costs.
So just click here to guarantee your free seat if you haven’t already…
<[link removed]>
And I’ll see you in a little while at 11 a.m. ET.
P.S. If you’re planning to attend on a mobile device, make sure you download
the presentation app now so you don’t miss anything when it starts. See you
there.
iOS: [link removed]
<[link removed]>
Android: [link removed]
<[link removed]>
Customer Story of the Day
"By FAR !! the best way to understand the workings in the stock market. Ross
and the team are the real deal, no BS.
I'm a lifetime full subscription member and couldn't be more satisfied."
Embrace the surge,
Ross Givens
Editor, Stock Surge Daily
You are receiving this email at
[email protected] because you are a
valued member of the Traders Agency Community.
If for any reason you believe you received this email in error, you can
safely ignore it, orclick here to unsubscribe
<[link removed]>
.
Stock Surge Daily
20 N Orange Ave Suite 1100, Orlando, FL 32801
© 2026 Stock Surge Daily. All Rights Reserved.
Archives <[link removed]> | Terms & Use
<[link removed]> | Privacy Policy
<[link removed]> | Unsubscribe
<[link removed]>
